Child: Clinical Trials

2 trials for Child, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 2

Follow Child: new trials by email Literature Review of Child trials Research Report on Child

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic-guided Dosing of Emicizumab
Emicizumab - PK-guided dose reduction, Emicizumab - Dosis continuation group, Emicizumab - Dose adjustment group - Hemophilia A With Inhibitor, Hemophilia A Without Inhibitor
Phase 4UnknownKathelijn Fischer952022-09-082024-03-20
Propofol for Treatment on Emergence Agitation
propofol - Child, Anesthesia Morbidity
Phase 4UnknownKorea University Anam Hospital1002016-04-012016-04-14

Narrower conditions

Emergence Delirium (1)  ·  Hemophilia A (1)  ·  Hemorrhage (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Coagulation Protein Disorders (1)  ·  Confusion (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Delirium (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)

Interventions

Propofol (1)  ·  emicizumab (1)

Sponsors

Kathelijn Fischer (1)  ·  Korea University Anam Hospital (1)

Countries

Netherlands (1)  ·  South Korea (1)

Top investigators

SeungZhoo Yoon, M.D.PhD. (1)

Results publications

PMID 35838993